SIETES :: 93212 citas

Resultados de la búsqueda por DOLOR DE CABEZA REFINAR BÚSQUEDA

1.

Parsons L. Moderna scores FDA panel backing for mRNA-based COVID-19 vaccine. PMLiVE 2020:18 de diciembre. [Ref.ID 103823]

2.

Doshi P. Pfizer and Moderna’s “95% effective” vaccines—let’s be cautious and first see the full data. BMJ 2020:26 de noviembre. [Ref.ID 103797]

3.

Thomas R. New Pfizer results: coronavirus vaccine is safe and 95% effective. N Y Times (Print) 2020:1. [Ref.ID 103781]

4.

Anderson EJ, Rouphael NG, Widge AT, Jackson LA, Roberts PC, Makhene M, Chappell JD, Denison MR, Stevens LJ, Pruijssers AJ, McDermott AB, Flach B, et al for the mRNA-1273 Study Group. Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults. N Engl J Med 2020;383:17 de diciembre. [Ref.ID 103729]

5.

Parsons L. Novavax reports promising phase 1 results for coronavirus vaccine. PMLiVE 2020:5 de agosto. [Ref.ID 103702]

6.

Boulware DR, Pullen MF, Bangdiwala AS, Pastik KA, Lofgren SM, Okafor EC, Skipper CP, Nascene AA, Nicol MR, Abassi M, Engen NW, Cheng MP, et al.. A randomized trial of hydroxychloroquine as postexposure prophylaxis for covid-19. N Engl J Med 2020;383:3 de junio. [Ref.ID 103646]

7.

Saragiotto BT, Abdel Shaheed C, Maher CG. Paracetamol for pain in adults. BMJ 2020;367:17 de enero. [Ref.ID 103510]

8.

Haight BR, Learned SM, Lafont CM, Fudala PJ, Zhao Y, Garofalo AS, Greenwald MK, Nadipelli VR, Linq W, Heidbreder C, RB-US-13-0001 Study Investigators. Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2019;393:23 de febrero. [Ref.ID 103111]

9.

Anónimo. FDA approves new treatment for osteoporosis in postmenopausal women at high risk of fracture. U.S. Food and Drug Administration 2019:9 de abril. [Ref.ID 103084]

10.

Chang AK, Bijur PE, Esses D, Barnaby DP, Baer J. Effect of a single dose of oral opioid and nonopioid analgesics on acute extremity pain in the emergency department. A randomized clinical trial. JAMA 2017;318:1661-7. [Ref.ID 102137]

11.

Powers SW, Coffey CS, Chamberlin LA, Ecklund DJ, Klingner EA, Yankey JW, Korbee LL, Porter LL, Hershey AD, for the CHAMP Investigators. Trial of amitriptyline, topiramate, and placebo for pediatric migraine. N Engl J Med 2017;376:115-24. [Ref.ID 101371]

12.

Amundsen S, Ovrebo TG, Amble NMS, Poole AC, Nordeng H. Use of antimigraine medications and information needs during pregnancy and breastfeeding: a cross-sectional study among 401 Norwegian women. Eur J Clin Pharmacol 2016;72:1525-35. [Ref.ID 101013]

13.

Anónimo. Aducanumab shows encouraging results as Alzheimer’s treatment in early clinical trial. DIA Daily 2016:3. [Ref.ID 100617]

14.

Anónimo. FDA approves Epclusa for treatment of chronic hepatitis C virus infection. U.S. Food and Drug Administration 2016:28 de junio. [Ref.ID 100447]

15.

Anonimo. Zecuity (sumatriptan) migraine patch: Drug Safety Communication - FDA evaluating risk of burns and scars. FDA MedWatch alert 2016:2 de junio. [Ref.ID 100411]

16.

Anónimo. Zecuity (sumatriptan) migraine patch: Drug Safety Communication - FDA evaluating risk of burns and scars. U.S. Food and Drug Administration 2016:2 de junio. [Ref.ID 100357]

17.

Wong J, Motulsky A, Eguale T, Buckeridge DL, Abrahamowicz M, Tamblyn R. Treatment indications for antidepressants prescribed in primary care in Quebec, Canada, 2006-2015. JAMA 2016;315:2230-2. [Ref.ID 100316]

18.

Wood ME, Frazier JA, Nordeng HME, Lapane KL. Prenatal triptan exposure and parent-reported early childhood neurodevelopmental outcomes: an application of propensity score calibration to adjust for unmeasured confounding by migraine severity. Pharmacoepidemiol Drug Saf 2016;25:493-502. [Ref.ID 100261]

19.

Anónimo. FDA approves new orphan drug to treat pulmonary arterial hypertension. U.S. Food and Drug Administration 2015:22 de diciembre. [Ref.ID 99740]

20.

Anónimo. FDA approves Nucala to treat severe asthma. U.S. Food and Drug Administration 2015:4 de noviembre. [Ref.ID 99610]